Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice

Journal of Neuroscience - United States
doi 10.1523/jneurosci.2131-15.2015
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Society for Neuroscience

Related search

MiR-7-1 Potentiated Estrogen Receptor Agonists for Functional Neuroprotection in VSC4.1 Motoneurons

Neuroscience
Neuroscience
2014English

Selective V1a Receptor Agonists in Experimental Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2007English

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2015English

Design of Subtype Selective Melatonin Receptor Agonists and Antagonists

Reproduction Nutrition Development
1999English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia

European Oncology and Haematology
OncologyHematology
2011English

Impact of Isotype Selective Estrogen Receptor Agonists on Ovarian Function

Experimental and Clinical Endocrinology and Diabetes
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy